The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data. [electronic resource]
Producer: 20181023Description: 761-765 p. digitalISSN:- 1473-5687
- Antiviral Agents -- adverse effects
- Benzimidazoles -- adverse effects
- Female
- Fluorenes -- adverse effects
- Hepacivirus -- drug effects
- Hepatitis C -- diagnosis
- Humans
- Immunosuppressive Agents -- therapeutic use
- Liver Cirrhosis -- diagnosis
- Liver Transplantation -- adverse effects
- Male
- Middle Aged
- Recurrence
- Retrospective Studies
- Ribavirin -- adverse effects
- Sofosbuvir
- Sustained Virologic Response
- Time Factors
- Treatment Outcome
- Uridine Monophosphate -- adverse effects
- Virus Activation -- drug effects
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.